Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akinao Okamoto

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Blood|April 8, 2020
HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DRKazuya Sakai, Masataka Kuwana, Hidenori Tanaka, et al.
Frontiers in Oncology|November 21, 2025
Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron eraAkinao Okamoto, Masahiro Yoshida, Senji Kasahara, et al.
Eclinicalmedicine|February 19, 2025
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): long-term results of a multicentre, single-arm, phase 2 trialKazuyuki Shimada, Motoko Yamaguchi, Yachiyo Kuwatsuka, et al.
Blood|January 29, 2021
Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphomaKazuyuki Shimada, Kenichi Yoshida, Yasuhiro Suzuki, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Blood|April 8, 2020
HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DRKazuya Sakai, Masataka Kuwana, Hidenori Tanaka, et al.
Frontiers in Oncology|November 21, 2025
Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron eraAkinao Okamoto, Masahiro Yoshida, Senji Kasahara, et al.
Eclinicalmedicine|February 19, 2025
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): long-term results of a multicentre, single-arm, phase 2 trialKazuyuki Shimada, Motoko Yamaguchi, Yachiyo Kuwatsuka, et al.
Blood|January 29, 2021
Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphomaKazuyuki Shimada, Kenichi Yoshida, Yasuhiro Suzuki, et al.
Pageof 4